Chargement en cours...
HER2 as a Therapeutic Target in Head and Neck Squamous Cell Carcinoma
The majority of patients with head and neck squamous cell carcinoma (HNSCC) present with advanced-stage disease. Current standard of care is surgery followed by adjuvant radiation therapy with or without chemotherapy or chemoradiation alone. The addition of cetuximab for the treatment of patients wi...
Enregistré dans:
| Publié dans: | Clin Cancer Res |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2014
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4315724/ https://ncbi.nlm.nih.gov/pubmed/25424855 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-14-1432 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|